SCHEMBL10696311

SCHEMBL10696311

Cc1cn2ncc(C(=O)O)c2nc1C

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 7/20 0.45
HSD17B10 Q99714 4/20 0.43
GAA P10253 1/20 0.43
TSHR P16473 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 3/20 0.41
TDP1 Q9NUW8 1/20 0.41
HPGD P15428 3/20 0.40
KMT2A Q03164 2/20 0.40
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TGFBR1 P36897 1/20 0.39
PDE2A O00408 1/20 0.36
GABRP O00591 2/20 0.36
GABRD O14764 2/20 0.36
GABRA1 P14867 2/20 0.36
GABRB1 P18505 2/20 0.36
GABRG2 P18507 2/20 0.36
GABRB3 P28472 2/20 0.36
GABRA5 P31644 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28521954 0.83 KDM4E (0.43) KDM4EHSD17B10GAATSHRSMN1; SMN2
SCHEMBL17781294 0.82 KDM4E (0.49) KDM4EHSD17B10GAATSHRSMN1; SMN2
SCHEMBL18208732 0.76 GABRP (0.44) KDM4EHSD17B10GAATSHRSMN1; SMN2
SCHEMBL17797439 0.75 KDM4E (0.40) KDM4EHSD17B10GAATSHRSMN1; SMN2
SCHEMBL4436848 0.75 HSD17B10 (0.48) KDM4EHSD17B10GAATSHRSMN1; SMN2
SCHEMBL29116932 0.74 IRAK4 (0.39) KDM4EHSD17B10ALDH1A1TDP1HPGD
SCHEMBL29116929 0.74 KDM4E (0.39) KDM4EHSD17B10ALDH1A1TDP1HPGD
SCHEMBL17781051 0.74 PDE2A (0.54) KDM4EHSD17B10GAATSHRSMN1; SMN2
SCHEMBL310126 0.74 PDE2A (0.59) KDM4EALDH1A1TDP1PDE2A
SCHEMBL32679866 0.73 KDM4E (0.50) KDM4EHSD17B10GAATSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3292107-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES Bayer Pharma Aktiengesellschaft (DE) 2018-03-14 EP disclosed
WO-2016177658-A1 AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2016-11-10 WO disclosed
EP-0254495-A2 Beta-Lactam compound, method for preparing the same, medicinal composition for bacterially infectious disease therapy containing the same and intermediates for synthesis of the same SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) 1988-01-27 EP disclosed